Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun

Updated on: May 25,2024 7

Drug mechanism opens door for new anti-cancer immunotherapies

by King's College LondonCredit: CC0 Public DomainResearchers have revealed a new mechanism of targeted drug treatment used against chronic lymphocytic leukemia, through the promotion of immun

Updated on:May 25,2024 7

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on: January 07,2024 9

Global disease burden related to nonmelanoma skin cancer explored

The disease burden attributable to nonmelanoma skin cancer (NMSC) is considerable and expected to continue increasing, according to a study published online July 30 inBMC Cancer.Wan Hu, from Anh

Updated on:January 07,2024 9

Appendiceal cancer gets its own preclinical model

byUniversity of California - San DiegoConfocal image of a living tissue slice derived from a patient tumor with metastatic appendiceal cancer (mucinous carcinomatosis peritonei). Immunofluoresce

Updated on: December 28,2023 9

Appendiceal cancer gets its own preclinical model

byUniversity of California - San DiegoConfocal image of a living tissue slice derived from a patient tumor with metastatic appendiceal cancer (mucinous carcinomatosis peritonei). Immunofluoresce

Updated on:December 28,2023 9

Non-melanoma skin cancer killing more people than melanoma, new study finds

by European Academy of Dermatology and VenerologyCredit: Unsplash/CC0 Public DomainNon-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of

Updated on: May 21,2024 7

Non-melanoma skin cancer killing more people than melanoma, new study finds

by European Academy of Dermatology and VenerologyCredit: Unsplash/CC0 Public DomainNon-melanoma skin cancer (NMSC) is causing a greater number of global deaths than melanoma, the more serious form of

Updated on:May 21,2024 7

Early-life alcohol intake may increase the odds of high-grade prostate cancer

by American Association for Cancer ResearchMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Compared with non-drink

Updated on: April 20,2024 14

Early-life alcohol intake may increase the odds of high-grade prostate cancer

by American Association for Cancer ResearchMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Compared with non-drink

Updated on:April 20,2024 14

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on: November 11,2024 0

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on:November 11,2024 0

Researchers study the risk of false positives in colon cancer screening

by IDIBELL-Bellvitge Biomedical Research InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer can develop for months without producing any s

Updated on: June 04,2024 8

Researchers study the risk of false positives in colon cancer screening

by IDIBELL-Bellvitge Biomedical Research InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer can develop for months without producing any s

Updated on:June 04,2024 8

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on: January 29,2024 10

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on:January 29,2024 10

Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center Deputy Director and Associate Dean for Research at the Colorado School of Public Health. Credit: University of Colorado Cancer Ce

Updated on: April 23,2024 16

Patients treated outside NCI centers less likely to receive high-cost lung cancer drugs

by CU Anschutz Medical CampusUniversity of Colorado Cancer Center Deputy Director and Associate Dean for Research at the Colorado School of Public Health. Credit: University of Colorado Cancer Ce

Updated on:April 23,2024 16

Study sheds light on mechanisms underlying H. pylori-induced gastric cancer

by Juntendo University Research Promotion CenterThe disruption of Wnt/PCP signaling by the oncoprotein CagA seems to promote gastric carcinogenesis. Credit: Atsushi Takahashi-Kanemitsu, Juntendo Unive

Updated on: February 20,2024 13

Study sheds light on mechanisms underlying H. pylori-induced gastric cancer

by Juntendo University Research Promotion CenterThe disruption of Wnt/PCP signaling by the oncoprotein CagA seems to promote gastric carcinogenesis. Credit: Atsushi Takahashi-Kanemitsu, Juntendo Unive

Updated on:February 20,2024 13

Rethinking the protein inhibitor approach to cancer therapy

byStony Brook UniversityTwo-step strategy for repeatable site-specific gene circuit integration.a, Network diagram of regulatory interactions and phenotypic impacts for native and ectopic

Updated on: January 22,2024 19

Rethinking the protein inhibitor approach to cancer therapy

byStony Brook UniversityTwo-step strategy for repeatable site-specific gene circuit integration.a, Network diagram of regulatory interactions and phenotypic impacts for native and ectopic

Updated on:January 22,2024 19

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on: March 30,2024 14

ASH: A+AVD beats ABVD for advanced Hodgkin's lymphoma

(HealthDay)—For patients with advanced-stage Hodgkin's lymphoma, brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A+AVD) have superior efficacy to doxorubicin, bleomycin, vinblastin

Updated on:March 30,2024 14